Chronic inflammation of the placenta: Definition, classification, pathogenesis, and clinical significance

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 4, 2015, Pages S53-S69

  Kim, Chong Jai ^a,b   Romero, Roberto ^b,c,d,e   Chaemsaithong, Piya ^b,e   Kim, Jung Sun ^b,f  

^a University of Ulsan College of Medicine   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

allograft; C4d; CD8; chemokine; chronic chorioamnionitis; chronic deciduitis; complement; CXCL10; fetal death; fetal growth restriction; HLA; maternal floor infarction; plasma cells; prematurity; rejection; T cell; tolerance; VUE

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA B ANTIGEN; HLA C ANTIGEN; HLA DM ANTIGEN; HLA DO ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; CHEMOKINE;

ANTIBODY MEDIATED REJECTION; ANTIGEN PRESENTATION; CHORIOAMNIONITIS; CHORION VILLUS; CHRONIC DECIDUITIS; CHRONIC INFLAMMATION; DISEASE CLASSIFICATION; FETAL INFLAMMATORY RESPONSE SYNDROME TYPE 2; FETUS WASTAGE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PATHOGENESIS; PLACENTA DISORDER; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPRODUCTION; REVIEW; SMALL FOR DATE INFANT; TOXOPLASMOSIS; VILLITIS OF UNKNOWN ETIOLOGY; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; DECIDUA; FEMALE; HISTOCOMPATIBILITY; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MICROBIOLOGY; PATHOLOGY; PLASMA CELL; PREGNANCY;

CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHORIOAMNIONITIS; CHORIONIC VILLI; CHRONIC DISEASE; DECIDUA; FEMALE; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; INFLAMMATION; MACROPHAGES; PLASMA CELLS; PREGNANCY;

EID: 84942564479     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.08.041     Document Type: Review

References (229)

1. Murphy HS. Inflammation. In: Strayer DS, Rubin E, editors. Rubin's Pathology. 6th ed. China: Lippincott Williams & Wilkins; 2012:47-82.
2. Benirschke K, Burton GJ, Baergen RN, editors. Infectious diseases. In: Pathology of the human placenta. 6th ed. Berlin: Springer; 2012:557-656.
3. Fox H, Sebire NJ. Infections and inflammatory lesions of the placenta. In: Pathology of the placenta. 3rd ed. China: Elsevier; 2007:303-54.
4. P.J. Katzman Chronic inflammatory lesions of the placenta Semin Perinatol 39 2015 20 26
5. G. Altshuler, and P. Russell The human placental villitides: a review of chronic intrauterine infection Curr Top Pathol 60 1975 64 112
6. D.M. Becroft, J.M. Thompson, and E.A. Mitchell Placental villitis of unknown origin: epidemiologic associations Am J Obstet Gynecol 192 2005 264 271
7. G. Boog Chronic villitis of unknown etiology Eur J Obstet Gynecol Reprod Biol 136 2008 9 15
8. K. Benirschke, R. Coen, B. Patterson, and T. Key Villitis of known origin: varicella and toxoplasma Placenta 20 1999 395 399
9. A.G. Garcia, N.G. Basso, M.E. Fonseca, J.A. Zuardi, and H.N. Outanni Enterovirus associated placental morphology: a light, virological, electron microscopic and immunohistologic study Placenta 12 1991 533 547
10. E. Euscher, J. Davis, I. Holzman, and G.J. Nuovo Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn Obstet Gynecol 98 2001 1019 1026
11. A. Satosar, N.C. Ramirez, D. Bartholomew, J. Davis, and G.J. Nuovo Histologic correlates of viral and bacterial infection of the placenta associated with severe morbidity and mortality in the newborn Hum Pathol 35 2004 536 545
12. A. O'Malley, and J.E. Gillan The incidence of viral infection causing villitis Placenta 26 2005 A.38
13. R.W. Redline Recurrent villitis of bacterial etiology Pediatr Pathol Lab Med 16 1996 995 1001
14. L.M. Ernst, J. Crouch, H. Rinder, and J.G. Howe Bacterial etiology for chronic villitis is not supported by polymerase chain reaction for 16S rRNA DNA Pediatr Dev Pathol 8 2005 647 653
15. M.J. Kim, R. Romero, C.J. Kim, and et al. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease J Immunol 182 2009 3919 3927
16. C.J. Kim, R. Romero, J.P. Kusanovic, and et al. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth Mod Pathol 23 2010 1000 1011
17. J. Lee, R. Romero, Y. Xu, and et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d PLoS One 6 2011 e16806
18. J. Lee, R. Romero, Y. Xu, and et al. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection Am J Reprod Immunol 66 2011 510 526
19. J. Lee, R. Romero, Z. Dong, and et al. Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies Histopathology 59 2011 928 938
20. J. Lee, R. Romero, T. Chaiworapongsa, and et al. Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response Am J Reprod Immunol 70 2013 265 284
21. J. Lee, R. Romero, Y. Xu, and et al. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery Am J Reprod Immunol 70 2013 162 175
22. K.A. Lee, Y.W. Kim, J.Y. Shim, and et al. Distinct patterns of C4d immunoreactivity in placentas with villitis of unknown etiology, cytomegaloviral placentitis, and infarct Placenta 34 2013 432 435
23. J. Lee, J.S. Kim, J.W. Park, and et al. Chronic chorioamnionitis is the most common placental lesion in late preterm birth Placenta 34 2013 681 689
24. E. Rudzinski, M. Gilroy, C. Newbill, and T. Morgan Positive C4d immunostaining of placental villous syncytiotrophoblasts supports host-versus-graft rejection in villitis of unknown etiology Pediatr Dev Pathol 16 2013 7 13
25. A. Erlebacher Why isn't the fetus rejected? Curr Opin Immunol 13 2001 590 593
26. J. Trowsdale, and A.G. Betz Mother's little helpers: mechanisms of maternal-fetal tolerance Nat Immunol 7 2006 241 246
27. M. Leslie Immunology: fetal immune system hushes attacks on maternal cells Science 322 2008 1450 1451
28. J.E. Mold, J. Michaelsson, T.D. Burt, and et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero Science 322 2008 1562 1565
29. W.J. Burlingham A lesson in tolerance-maternal instruction to fetal cells N Engl J Med 360 2009 1355 1357
30. J.A. Bluestone Mechanisms of tolerance Immunol Rev 241 2011 5 19
31. J.H. Rowe, J.M. Ertelt, L. Xin, and S.S. Way Pregnancy imprints regulatory memory that sustains anergy to fetal antigen Nature 490 2012 102 106
32. A.G. Betz Immunology: tolerating pregnancy Nature 490 2012 47 48
33. Z. Williams Inducing tolerance to pregnancy N Engl J Med 367 2012 1159 1161
34. A. Erlebacher Mechanisms of T cell tolerance towards the allogeneic fetus Nat Rev Immunol 13 2013 23 33
35. J.S. Kim, R. Romero, M.R. Kim, and et al. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology Histopathology 52 2008 457 464
36. S. Segerer, Y. Cui, F. Eitner, and et al. Expression of chemokines and chemokine receptors during human renal transplant rejection Am J Kidney Dis 37 2001 518 531
37. N.M. Fahmy, M.H. Yamani, R.C. Starling, and et al. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants Transplantation 75 2003 72 78
38. M. Rotondi, A. Rosati, A. Buonamano, and et al. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure Am J Transplant 4 2004 1466 1474
39. R.R. Tatapudi, T. Muthukumar, D. Dadhania, and et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine Kidney Int 65 2004 2390 2397
40. S. Segerer, G.A. Bohmig, M. Exner, D. Kerjaschki, H. Regele, and D. Schlondorff Role of CXCR3 in cellular but not humoral renal allograft rejection Transpl Int 18 2005 676 680
41. E. Lazzeri, M. Rotondi, B. Mazzinghi, and et al. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy Transplantation 79 2005 1215 1220
42. S. Schaub, P. Nickerson, D. Rush, and et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis Am J Transplant 9 2009 1347 1353
43. C. Crescioli, A. Buonamano, S. Scolletta, and et al. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection Transplantation 87 2009 249 255
44. S.A. Hoffman, L. Wang, C.V. Shah, and et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation Am J Transplant 9 2009 389 396
45. Y. Mao, M. Wang, Q. Zhou, and et al. CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy J Clin Immunol 31 2011 414 418
46. D.J. Lo, T.A. Weaver, D.E. Kleiner, and et al. Chemokines and their receptors in human renal allotransplantation Transplantation 91 2011 70 77
47. P. Romagnani, and C. Crescioli CXCL10: a candidate biomarker in transplantation Clin Chim Acta 413 2012 1364 1373
48. M. Suthanthiran, J.E. Schwartz, R. Ding, and et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts N Engl J Med 369 2013 20 31
49. Q. Zhang, Y.F. Liu, Z.X. Su, L.P. Shi, and Y.H. Chen Serum fractalkine and interferon-gamma inducible protein-10 concentrations are early detection markers for acute renal allograft rejection Transplant Proc 46 2014 1420 1425
50. R.W. Redline, and P. Patterson Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells Am J Pathol 143 1993 473 479
51. D. Myerson, R.K. Parkin, K. Benirschke, C.N. Tschetter, and S.R. Hyde The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells Pediatr Dev Pathol 9 2006 257 265
52. W.F. Knox, and H. Fox Villitis of unknown aetiology: its incidence and significance in placentae from a British population Placenta 5 1984 395 402
53. R.W. Redline, and C.R. Abramowsky Clinical and pathologic aspects of recurrent placental villitis Hum Pathol 16 1985 727 731
54. R.W. Redline Villitis of unknown etiology: noninfectious chronic villitis in the placenta Hum Pathol 38 2007 1439 1446
55. L. Feeley, and E.E. Mooney Villitis of unknown aetiology: correlation of recurrence with clinical outcome J Obstet Gynaecol 30 2010 476 479
56. J.A. Tamblyn, D.M. Lissauer, R. Powell, P. Cox, and M.D. Kilby The immunological basis of villitis of unknown etiology: review Placenta 34 2013 846 855
57. Z. Tang, V.M. Abrahams, G. Mor, and S. Guller Placental Hofbauer cells and complications of pregnancy Ann N Y Acad Sci 1221 2011 103 108
58. P.J. Katzman, S.P. Murphy, and D.A. Oble Immunohistochemical analysis reveals an influx of regulatory T cells and focal trophoblastic STAT-1 phosphorylation in chronic villitis of unknown etiology Pediatr Dev Pathol 14 2011 284 293
59. V.R. Aluvihare, M. Kallikourdis, and A.G. Betz Regulatory T cells mediate maternal tolerance to the fetus Nat Immunol 5 2004 266 271
60. D.A. Somerset, Y. Zheng, M.D. Kilby, D.M. Sansom, and M.T. Drayson Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset Immunology 112 2004 38 43
61. M.P. Piccinni T cell tolerance towards the fetal allograft J Reprod Immunol 85 2010 71 75
62. A. Leber, A. Teles, and A.C. Zenclussen Regulatory T cells and their role in pregnancy Am J Reprod Immunol 63 2010 445 459
63. A. Schumacher, and A.C. Zenclussen Regulatory T cells: regulators of life Am J Reprod Immunol 72 2014 158 170
64. Y. Ito, K. Matsuoka, T. Uesato, and et al. Increased expression of perforin, granzyme B, and C5b-9 in villitis of unknown etiology Placenta 36 2015 531 537
65. P. Russell Inflammatory lesions of the human placenta; III, The histopathology of villitis of unknown aetiology Placenta 1 1980 227 244
66. R.W. Redline, and M.A. O'Riordan Placental lesions associated with cerebral palsy and neurologic impairment following term birth Arch Pathol Lab Med 124 2000 1785 1791
67. R.W. Redline Severe fetal placental vascular lesions in term infants with neurologic impairment Am J Obstet Gynecol 192 2005 452 457
68. J. Xiao, M. Garcia-Lloret, B. Winkler-Lowen, R. Miller, K. Simpson, and L.J. Guilbert ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis Am J Pathol 150 1997 1845 1860
69. P.B. Juliano, M.H. Blotta, and A.M. Altemani ICAM-1 is overexpressed by villous trophoblasts in placentitis Placenta 27 2006 750 757
70. C.A. Labarrere, E. Bammerlin, J.W. Hardin, and H.L. Dicarlo Intercellular adhesion molecule-1 expression in massive chronic intervillositis: implications for the invasion of maternal cells into fetal tissues Placenta 35 2014 311 317
71. E.S. Egal, F.V. Mariano, M.H. Blotta, and et al. ICAM-1 expression on immune cells in chronic villitis Placenta 35 2014 1021 1026
72. D.M. Nelson Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast Placenta 17 1996 387 391
73. E. Akalin, R.C. Hendrix, R.G. Polavarapu, and et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology Transplantation 72 2001 948 953
74. V.J. Gimino, J.D. Lande, T.R. Berryman, R.A. King, and M.I. Hertz Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection Am J Respir Crit Care Med 168 2003 1237 1242
75. T. Ichiba, T. Teshima, R. Kuick, and et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays Blood 102 2003 763 771
76. S.M. Flechner, S.M. Kurian, S.R. Head, and et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes Am J Transplant 4 2004 1475 1489
77. P.B. Sugerman, S.B. Faber, L.M. Willis, and et al. Kinetics of gene expression in murine cutaneous graft-versus-host disease Am J Pathol 164 2004 2189 2202
78. M.C. Deng, H.J. Eisen, M.R. Mehra, and et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling Am J Transplant 6 2006 150 160
79. C. Jeanty, S.C. Derderian, and T.C. Mackenzie Maternal-fetal cellular trafficking: clinical implications and consequences Curr Opin Pediatr 26 2014 377 382
80. R. Romero, S.J. Korzeniewski, T. Chaiwaropongsa, and et al. Histologic features of placentas delivered by low-risk women with singleton term gestations Am J Obstet Gynecol (in preparation) 2015
81. C. Labarrere, O. Althabe, and M. Telenta Chronic villitis of unknown aetiology in placentae of idiopathic small for gestational age infants Placenta 3 1982 309 317
82. C. Labarrere, and O. Althabe Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies Eur J Obstet Gynecol Reprod Biol 20 1985 1 11
83. O. Althabe, and C. Labarrere Chronic villitis of unknown aetiology and intrauterine growth-retarded infants of normal and low ponderal index Placenta 6 1985 369 373
84. C.M. Salafia, A.M. Vintzileos, L. Silberman, K.F. Bantham, and C.A. Vogel Placental pathology of idiopathic intrauterine growth retardation at term Am J Perinatol 9 1992 179 184
85. R.W. Redline, and P. Patterson Patterns of placental injury: correlations with gestational age, placental weight, and clinical diagnoses Arch Pathol Lab Med 118 1994 698 701
86. C.M. Salafia, V.K. Minior, J.C. Pezzullo, E.J. Popek, T.S. Rosenkrantz, and A.M. Vintzileos Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features Am J Obstet Gynecol 173 1995 1049 1057
87. H. Derricott, R.L. Jones, and A.E. Heazell Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction: a systematic review Placenta 34 2013 856 862
88. C.M. Salafia, C.A. Vogel, A.M. Vintzileos, K.F. Bantham, J. Pezzullo, and L. Silberman Placental pathologic findings in preterm birth Am J Obstet Gynecol 165 1991 934 938
89. J.H. Veerbeek, P.G. Nikkels, H.L. Torrance, and et al. Placental pathology in early intrauterine growth restriction associated with maternal hypertension Placenta 35 2014 696 701
90. S. Benzon, S. Zekic Tomas, Z. Benzon, M. Vulic, and I. Kuzmic Prusac Involvement of T lymphocytes in the placentae with villitis of unknown etiology from pregnancies complicated with preeclampsia J Matern Fetal Neonatal Med 2015 Epub ahead of print
91. R.W. Redline, M. Zaragoza, and T. Hassold Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions Hum Pathol 30 1999 93 100
92. R. Romero Prenatal medicine: the child is the father of the man, 1996 J Matern Fetal Neonatal Med 22 2009 636 639
93. G.C. Di Renzo The great obstetrical syndromes J Matern Fetal Neonatal Med 22 2009 633 635
94. I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero The "Great Obstetrical Syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
95. H.L. Torrance, M.C. Bloemen, E.J. Mulder, and et al. Predictors of outcome at 2 years of age after early intrauterine growth restriction Ultrasound Obstet Gynecol 36 2010 171 177
96. M.S. Scher, G.S. Trucco, M.E. Beggarly, D.A. Steppe, and T.A. Macpherson Neonates with electrically confirmed seizures and possible placental associations Pediatr Neurol 19 1998 37 41
97. A.M. Eberle, D. Levesque, A.M. Vintzileos, J.F. Egan, V. Tsapanos, and C.M. Salafia Placental pathology in discordant twins Am J Obstet Gynecol 169 1993 931 935
98. S.M. Jacques, and F. Qureshi Chronic villitis of unknown etiology in twin gestations Pediatr Pathol 14 1994 575 584
99. A.K. Styer, H.J. Parker, D.J. Roberts, D. Palmer-Toy, T.L. Toth, and J.L. Ecker Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy Am J Obstet Gynecol 189 2003 1184 1186
100. S.C. Perni, M. Predanic, J.E. Cho, and R.N. Baergen Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies J Perinat Med 33 2005 27 32
101. F. Gundogan, D.W. Bianchi, S.A. Scherjon, and D.J. Roberts Placental pathology in egg donor pregnancies Fertil Steril 93 2010 397 404
102. D.J. Gersell, N.J. Phillips, and K. Beckerman Chronic chorioamnionitis: a clinicopathologic study of 17 cases Int J Gynecol Pathol 10 1991 217 229
103. D.J. Gersell Chronic villitis, chronic chorioamnionitis, and maternal floor infarction Semin Diagn Pathol 10 1993 251 266
104. S.M. Jacques, and F. Qureshi Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study Hum Pathol 29 1998 1457 1461
105. J. Krol, K. Mengele, I. Ottl-Mantchenko, and et al. Ex vivo detection of apoptotic trophoblast cells applying flow cytofluorometry and immunocytochemistry using M30 antibody directed to the cytokeratin 18 neo-epitope Int J Mol Med 16 2005 415 420
106. S. Kovats, E.K. Main, C. Librach, M. Stubblebine, S.J. Fisher, and R. Demars A class I antigen, HLA-G, expressed in human trophoblasts Science 248 1990 220 223
107. M.T. Mcmaster, C.L. Librach, Y. Zhou, and et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts J Immunol 154 1995 3771 3778
108. A. Ishitani, N. Sageshima, N. Lee, and et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition J Immunol 171 2003 1376 1384
109. J.S. Hunt, M.G. Petroff, R.H. Mcintire, and C. Ober HLA-G and immune tolerance in pregnancy FASEB J 19 2005 681 693
110. P. Nancy, E. Tagliani, C.S. Tay, P. Asp, D.E. Levy, and A. Erlebacher Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface Science 336 2012 1317 1321
111. A.C. Zenclussen, K. Gerlof, M.L. Zenclussen, and et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model Am J Pathol 166 2005 811 822
112. Y. Sasaki, M. Sakai, S. Miyazaki, S. Higuma, A. Shiozaki, and S. Saito Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases Mol Hum Reprod 10 2004 347 353
113. D.H. Munn, M. Zhou, J.T. Attwood, and et al. Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193
114. J.S. Hunt, D. Vassmer, T.A. Ferguson, and L. Miller Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus J Immunol 158 1997 4122 4128
115. C.H. Holmes, K.L. Simpson, S.D. Wainwright, and et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy J Immunol 144 1990 3099 3105
116. B.L. Hsi, J.S. Hunt, and J.P. Atkinson Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells J Reprod Immunol 19 1991 209 223
117. I. Guleria, A. Khosroshahi, M.J. Ansari, and et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance J Exp Med 202 2005 231 237
118. A.G. Garcia, R.L. Marques, Y.Y. Lobato, M.E. Fonseca, and M.D. Wigg Placental pathology in congenital rubella Placenta 6 1985 281 295
119. A.G. Garcia Congenital toxoplasmosis in two successive sibs Arch Dis Child 43 1968 705 710
120. R. Romero, M. Ceska, C. Avila, M. Mazor, E. Behnke, and I. Lindley Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition Am J Obstet Gynecol 165 1991 813 820
121. P.H. Cherouny, G.A. Pankuch, R. Romero, and et al. Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants Am J Obstet Gynecol 169 1993 1299 1303
122. T. Puchner, C. Egarter, C. Wimmer, F. Lederhilger, and I. Weichselbraun Amniotic fluid interleukin-8 as a marker for intraamniotic infection Arch Gynecol Obstet 253 1993 9 14
123. R. Gomez, F. Ghezzi, R. Romero, H. Munoz, J.E. Tolosa, and I. Rojas Premature labor and intra-amniotic infection: clinical aspects and role of the cytokines in diagnosis and pathophysiology Clin Perinatol 22 1995 281 342
124. B.H. Yoon, R. Romero, J.K. Jun, and et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia Am J Obstet Gynecol 177 1997 825 830
125. F. Ghezzi, R. Gomez, R. Romero, and et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia Eur J Obstet Gynecol Reprod Biol 78 1998 5 10
126. C.D. Hsu, E. Meaddough, K. Aversa, and et al. Elevated amniotic fluid levels of leukemia inhibitory factor, interleukin 6, and interleukin 8 in intra-amniotic infection Am J Obstet Gynecol 179 1998 1267 1270
127. C.D. Hsu, E. Meaddough, K. Aversa, and J.A. Copel The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection Am J Obstet Gynecol 178 1998 428 432
128. R. Figueroa, D. Garry, A. Elimian, K. Patel, P.B. Sehgal, and N. Tejani Evaluation of amniotic fluid cytokines in preterm labor and intact membranes J Matern Fetal Neonatal Med 18 2005 241 247
129. S. Yoneda, A. Shiozaki, M. Ito, and et al. Accurate prediction of the stage of histological chorioamnionitis before delivery by amniotic fluid IL-8 level Am J Reprod Immunol 73 2015 568 576
130. G. Ogge, R. Romero, D.C. Lee, and et al. Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome J Pathol 223 2011 553 565
131. A. Alok, D. Mukhopadhyay, and A.A. Karande Glycodelin A, an immunomodulatory protein in the endometrium, inhibits proliferation and induces apoptosis in monocytic cells Int J Biochem Cell Biol 41 2009 1138 1147
132. K. Lannaman, R. Romero, P. Chaemsaithong, and et al. Fetal death: an extreme form of maternal anti-fetal rejection (Abstract 497) Am J Obstet Gynecol 212 suppl 2015 S251
133. T.Y. Khong, R.W. Bendon, F. Qureshi, and et al. Chronic deciduitis in the placental basal plate: definition and interobserver reliability Hum Pathol 31 2000 292 295
134. F.T. Kraus, R.W. Redline, D.J. Gersell, D.M. Nelson, and J.M. Dicke Inflammation and infection. Placental Pathology: Atlas of Nontumor Pathology (First Series, Fascicle 3) 2004 American Registry of Pathology Washington (DC) 75 115
135. R.L. Naeye Functionally important disorders of the placenta, umbilical cord, and fetal membranes Hum Pathol 18 1987 680 691
136. R.W. Bendon, and M. Miller Routine pathological examination of placentae from abnormal pregnancies Placenta 11 1990 369 370
137. L.L. Maroun, L. Mathiesen, M. Hedegaard, L.E. Knudsen, and L.G. Larsen Pathologic evaluation of normal and perfused term placental tissue Pediatr Dev Pathol 17 2014 330 338
138. N. Edmondson, A. Bocking, G. Machin, R. Rizek, C. Watson, and S. Keating The prevalence of chronic deciduitis in cases of preterm labor without clinical chorioamnionitis Pediatr Dev Pathol 12 2009 16 21
139. C.A. Koch, and J.L. Platt Natural mechanisms for evading graft rejection: the fetus as an allograft Springer Semin Immunopathol 25 2003 95 117
140. G. Chaouat, M. Petitbarat, S. Dubanchet, M. Rahmati, and N. Ledee Tolerance to the foetal allograft? Am J Reprod Immunol 63 2010 624 636
141. A. Moffett, and C. Loke Immunology of placentation in eutherian mammals Nat Rev Immunol 6 2006 584 594
142. A. Erlebacher, D. Vencato, K.A. Price, D. Zhang, and L.H. Glimcher Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus J Clin Invest 117 2007 1399 1411
143. J. Szekeres-Bartho Immunological relationship between the mother and the fetus Int Rev Immunol 21 2002 471 495
144. A. Erlebacher Immunology of the maternal-fetal interface Annu Rev Immunol 31 2013 387 411
145. A. Le Moine, M. Goldman, and D. Abramowicz Multiple pathways to allograft rejection Transplantation 73 2002 1373 1381
146. R.B. Colvin, and R.N. Smith Antibody-mediated organ-allograft rejection Nat Rev Immunol 5 2005 807 817
147. M.L. Alegre, S. Florquin, and M. Goldman Cellular mechanisms underlying acute graft rejection: time for reassessment Curr Opin Immunol 19 2007 563 568
148. I.K. Kim, D.S. Bedi, C. Denecke, X. Ge, and S.G. Tullius Impact of innate and adaptive immunity on rejection and tolerance Transplantation 86 2008 889 894
149. L.D. Cornell, R.N. Smith, and R.B. Colvin Kidney transplantation: mechanisms of rejection and acceptance Annu Rev Pathol 3 2008 189 220
150. B.J. Nankivell, and S.I. Alexander Rejection of the kidney allograft N Engl J Med 363 2010 1451 1462
151. K.J. Wood, and R. Goto Mechanisms of rejection: current perspectives Transplantation 93 2012 1 10
152. J.M. Ali, E.M. Bolton, J.A. Bradley, and G.J. Pettigrew Allorecognition pathways in transplant rejection and tolerance Transplantation 96 2013 681 688
153. R.M. Mckenna, S.K. Takemoto, and P.I. Terasaki Anti-HLA antibodies after solid organ transplantation Transplantation 69 2000 319 326
154. E.K. Ho, G. Vlad, A.I. Colovai, and et al. Alloantibodies in heart transplantation Hum Immunol 70 2009 825 829
155. W.M. Howell, V. Carter, and B. Clark The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques J Clin Pathol 63 2010 387 390
156. M.A. Ayala Garcia, B. Gonzalez Yebra, A.L. Lopez Flores, and E. Guani Guerra The major histocompatibility complex in transplantation J Transplant 2012 2012 842141
157. B.M. Mahdi A glow of HLA typing in organ transplantation Clin Transl Med 2 2013 6
158. R.H. Buckley Transplantation immunology: organ and bone marrow J Allergy Clin Immunol 111 suppl 2003 S733 S744
159. Y. Xu, F. Tarquini, R. Romero, and et al. Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis Am J Reprod Immunol 67 2012 184 197
160. X.C. Li, and M. Raghavan Structure and function of major histocompatibility complex class I antigens Curr Opin Organ Transplant 15 2010 499 504
161. E.W. Petersdorf The major histocompatibility complex: a model for understanding graft-versus-host disease Blood 122 2013 1863 1872
162. E.W. Petersdorf Genetics of graft-versus-host disease: the major histocompatibility complex Blood Rev 27 2013 1 12
163. F. Kissmeyer-Nielsen, S. Olsen, V.P. Petersen, and O. Fjeldborg Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells Lancet 2 1966 662 665
164. S. Sumitran-Holgersson HLA-specific alloantibodies and renal graft outcome Nephrol Dial Transplant 16 2001 897 904
165. P.C. Lee, L. Zhu, P.I. Terasaki, and M.J. Everly HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss Transplantation 88 2009 568 574
166. J.M. Gloor, J.L. Winters, L.D. Cornell, and et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation Am J Transplant 10 2010 582 589
167. R.A. Montgomery, E. Cozzi, L.J. West, and D.S. Warren Humoral immunity and antibody-mediated rejection in solid organ transplantation Semin Immunol 23 2011 224 234
168. D. Focosi, F. Vistoli, and U. Boggi Rejection of the kidney allograft N Engl J Med 364 2011 485 486
169. R.A. Montgomery, B.E. Lonze, K.E. King, and et al. Desensitization in HLA-incompatible kidney recipients and survival N Engl J Med 365 2011 318 326
170. S. Mohan, A. Palanisamy, D. Tsapepas, and et al. Donor-specific antibodies adversely affect kidney allograft outcomes J Am Soc Nephrol 23 2012 2061 2071
171. O. Thaunat Humoral immunity in chronic allograft rejection: puzzle pieces come together Transpl Immunol 26 2012 101 106
172. G. Honger, I. Fornaro, C. Granado, J.M. Tiercy, I. Hosli, and S. Schaub Frequency and determinants of pregnancy-induced child-specific sensitization Am J Transplant 13 2013 746 753
173. M. Jones, H. Jeal, J.M. Harris, and et al. Association of maternal anti-HLA class II antibodies with protection from allergy in offspring Allergy 68 2013 1143 1149
174. E. Masson, C. Vidal, M. Deschamps, S. Bongain, C. Thevenin, I. Dupont, and et al. Incidence and risk factors of anti-HLA immunization after pregnancy Hum Immunol 74 2013 946 951
175. E.E. Lashley, T. Meuleman, and F.H. Claas Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis Am J Reprod Immunol 70 2013 87 103
176. R. Romero, A. Whitten, S.J. Korzeniewski, and et al. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? Am J Reprod Immunol 70 2013 285 298
177. A.E. Whitten, R. Romero, S.J. Korzeniewski, and et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction); a placental lesion associated with recurrent miscarriage and fetal death Am J Obstet Gynecol 208 2013 310.e1 310.e11
178. R. Gomez, R. Romero, F. Ghezzi, B.H. Yoon, M. Mazor, and S.M. Berry The fetal inflammatory response syndrome Am J Obstet Gynecol 179 1998 194 202
179. B.H. Yoon, R. Romero, J.S. Park, and et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis Am J Obstet Gynecol 183 2000 1124 1129
180. L.F. Goncalves, T. Chaiworapongsa, and R. Romero Intrauterine infection and prematurity Ment Retard Dev Disabil Res Rev 8 2002 3 13
181. F. Gotsch, R. Romero, J.P. Kusanovic, and et al. The fetal inflammatory response syndrome Clin Obstet Gynecol 50 2007 652 683
182. R. Romero, S.K. Dey, and S.J. Fisher Preterm labor: one syndrome, many causes Science 345 2014 760 765
183. P. Pacora, T. Chaiworapongsa, E. Maymon, and et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome J Matern Fetal Neonatal Med 11 2002 18 25
184. C.J. Kim, R. Romero, P. Chaemsaithong, and Y.M. Kim Acute chorionitis and funisitis: Definition, Pathologic features, and clinical significance Am J Obstet Gynecol (in preparation) 2015
185. D.D. Taub, A.R. Lloyd, K. Conlon, and et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells J Exp Med 177 1993 1809 1814
186. D.D. Taub, T.J. Sayers, C.R. Carter, and J.R. Ortaldo Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis J Immunol 155 1995 3877 3888
187. M. Loetscher, B. Gerber, P. Loetscher, and et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes J Exp Med 184 1996 963 969
188. P. Romagnani, L. Lasagni, F. Annunziato, M. Serio, and S. Romagnani CXC chemokines: the regulatory link between inflammation and angiogenesis Trends Immunol 25 2004 201 209
189. E. Lazzeri, and P. Romagnani CXCR3-binding chemokines: novel multifunctional therapeutic targets Curr Drug Targets Immune Endocr Metabol Disord 5 2005 109 118
190. J. Tan, and G. Zhou Chemokine receptors and transplantation Cell Mol Immunol 2 2005 343 349
191. P. Romagnani From basic science to clinical practice: use of cytokines and chemokines as therapeutic targets in renal diseases J Nephrol 18 2005 229 233
192. C. Agostini, F. Calabrese, F. Rea, and et al. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection Am J Pathol 158 2001 1703 1711
193. N.M. Fahmy, M.H. Yamani, R.C. Starling, and et al. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts Transplantation 75 2003 2044 2047
194. B.D. Kamath, M.P. Marcotte, and E.A. Defranco Neonatal morbidity after documented fetal lung maturity in late preterm and early term infants Am J Obstet Gynecol 204 2011 518.e1 518.e8
195. M.J. Teune, S. Bakhuizen, C. Gyamfi Bannerman, and et al. A systematic review of severe morbidity in infants born late preterm Am J Obstet Gynecol 205 2011 374.e1 374.e9
196. H.G. Taylor Outcomes of late preterm birth: who is at risk and for what? Am J Obstet Gynecol 206 2012 181 182
197. H.S. Lipkind, M.E. Slopen, M.R. Pfeiffer, and K.H. Mcveigh School-age outcomes of late preterm infants in New York City Am J Obstet Gynecol 206 2012 222.e1 222.e6
198. V. Zanardo, G. Straface, and D. Trevisanuto Future learning abilities of late preterm infants Am J Obstet Gynecol 207 2012 e17 e18
199. R. Kessous, I. Shoham-Vardi, G. Pariente, G. Holcberg, and E. Sheiner An association between preterm delivery and long-term maternal cardiovascular morbidity Am J Obstet Gynecol 209 2013 368.e1 368.e8
200. K.A. Berry, I.S. Baron, B.A. Weiss, R. Baker, M.D. Ahronovich, and F.R. Litman In vitro fertilization and late preterm preschoolers' neuropsychological outcomes: the PETIT study Am J Obstet Gynecol 209 2013 356.e1 356.e6
201. K. Heinonen, J.G. Eriksson, J. Lahti, and et al. Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study Pediatrics 135 2015 e818 e825
202. M.H. Larsen, and T.V. Hviid Human leukocyte antigen-G polymorphism in relation to expression, function, and disease Hum Immunol 70 2009 1026 1034
203. D. Uckan, A. Steele, Cherry, and et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion Mol Hum Reprod 3 1997 655 662
204. Y. Kudo, and C.A. Boyd Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection Biochim Biophys Acta 1500 2000 119 124
205. A.L. Mellor, J. Sivakumar, P. Chandler, and et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy Nat Immunol 2 2001 64 68
206. A.L. Mellor, P. Chandler, G.K. Lee, and et al. Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy J Reprod Immunol 57 2002 143 150
207. Y. Kudo The role of placental indoleamine 2,3-dioxygenase in human pregnancy Obstet Gynecol Sci 56 2013 209 216
208. A. Habicht, S. Dada, M. Jurewicz, and et al. A link between PDL1 and T regulatory cells in fetomaternal tolerance J Immunol 179 2007 5211 5219
209. F. D'addio, L.V. Riella, B.G. Mfarrej, and et al. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance J Immunol 187 2011 4530 4541
210. C.H. Holmes, K.L. Simpson, H. Okada, and et al. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55) Eur J Immunol 22 1992 1579 1585
211. F. Tedesco, G. Narchi, O. Radillo, S. Meri, S. Ferrone, and C. Betterle Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins J Immunol 151 1993 1562 1570
212. C. Xu, D. Mao, V.M. Holers, B. Palanca, A.M. Cheng, and H. Molina A critical role for murine complement regulator crry in fetomaternal tolerance Science 287 2000 498 501
213. G. Girardi, R. Bulla, J.E. Salmon, and F. Tedesco The complement system in the pathophysiology of pregnancy Mol Immunol 43 2006 68 77
214. G. Girardi Complement inhibition keeps mothers calm and avoids fetal rejection Immunol Invest 37 2008 645 659
215. D.P. Stites, S. Bugbee, and P.K. Siiteri Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation: relevance to immunosuppression in pregnancy J Reprod Immunol 5 1983 215 228
216. P.K. Siiteri, F. Febres, L.E. Clemens, R.J. Chang, B. Gondos, and D. Stites Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci 286 1977 384 397
217. J. Szekeres-Bartho, and T.G. Wegmann A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance J Reprod Immunol 31 1996 81 95
218. G. Mao, J. Wang, Y. Kang, and et al. Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice Endocrinology 151 2010 5477 5488
219. J.H. Lee, B. Ulrich, J. Cho, J. Park, and C.H. Kim Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells J Immunol 187 2011 1778 1787
220. L. Mincheva-Nilsson, O. Nagaeva, T. Chen, and et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival J Immunol 176 2006 3585 3592
221. L. Mincheva-Nilsson, and V. Baranov The role of placental exosomes in reproduction Am J Reprod Immunol 63 2010 520 533
222. M. Mangeney, M. Renard, G. Schlecht-Louf, and et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins Proc Natl Acad Sci U S A 104 2007 20534 20539
223. J.M. Tolosa, J.E. Schjenken, V.L. Clifton, and et al. The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-stimulated cytokine responses in human blood and is sorted into placental exosomes Placenta 33 2012 933 941
224. A. Sabapatha, C. Gercel-Taylor, and D.D. Taylor Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences Am J Reprod Immunol 56 2006 345 355
225. D.D. Taylor, S. Akyol, and C. Gercel-Taylor Pregnancy-associated exosomes and their modulation of T cell signaling J Immunol 176 2006 1534 1542
226. M. Hedlund, A.C. Stenqvist, O. Nagaeva, and et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function J Immunol 183 2009 340 351
227. A. Makrigiannakis, E. Zoumakis, S. Kalantaridou, and et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance Nat Immunol 2 2001 1018 1024
228. L. Frangsmyr, V. Baranov, O. Nagaeva, U. Stendahl, L. Kjellberg, and L. Mincheva-Nilsson Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level Mol Hum Reprod 11 2005 35 41
229. A.C. Stenqvist, O. Nagaeva, V. Baranov, and L. Mincheva-Nilsson Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus J Immunol 191 2013 5515 5523